TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II
Condition:   Lymphoblastic Leukemia Interventions:   Drug: Dexamethasone;   Drug: Mitoxantrone;   Drug: PEG asparaginase;   Drug: Bortezomib;   Drug: Vorinostat;   Drug: Mercaptopurine;   Drug: Methotrexate;   Drug: Blinatumomab;   Drug: Ziftomenib Sponsors:   Stanford University;   Pediatric Oncology Experimental Therapeutics Investigators' Consortium;   Amgen;   Lucile Packard Children's Hospital Foundation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 8, 2023 Category: Research Source Type: clinical trials